Advertisement
Screener

SONOMA PHARMACEUTICALS, INC. (SNOA) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

SONOMA PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where SONOMA PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-03-31: from running the business, $3.93M went out.
  • Fiscal year ended 2026-03-31: from investing, $192.00K went out.
  • Fiscal year ended 2026-03-31: from financing, $477.00K came in.
  • Fiscal year ended 2026-03-31: change in cash, $2.98M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtCommercial paperNew shares soldNot split outChange in cash
2026-03-31-$3.93M-$192.00K-$271.00K$427.00K-$2.98M
2025-03-31-$88.00K-$80.00K-$404.00K$3.08M$2.25M
2024-03-31-$2.40M-$2.00K-$481.00K$1.78M-$692.00K
2023-03-31-$6.15M-$258.00K-$774.00K$2.87M-$3.58M
2022-03-31-$4.25M-$99.00K-$30.00K$7.55M$3.18M
2021-03-31-$3.38M$388.00K$0.00$3.31M*$529.00K
2020-03-31-$4.59M$3.64M-$334.00K$1.38M$2.00K
2019-03-31-$11.72M-$131.00K-$154.00K$957.00K$4.69M*-$6.38M
2018-03-31-$12.44M-$201.00K-$148.00K$968.00K$4.42M*-$7.39M
2017-03-31-$8.17M$18.22M-$130.00K$0.00$9.99M
2016-03-31-$8.75M$4.19M-$119.00K$6.14M$1.33M
2015-03-31-$6.69M$875.00K-$176.00K$6.79M*$656.00K
2014-03-31-$4.89M-$445.00K-$1.61M*$3.19M-$2.42M
2013-03-31$1.15M-$370.00K-$2.08M$0.00$4.94M$891.00K*$4.55M
2012-03-31-$4.03M-$360.00K-$1.16M$2.50M$1.89M-$1.02M
2011-03-31-$4.43M-$164.00K-$410.00K$3.00M$94.00K-$1.89M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$649.00K-$2.00K-$82.00K$3.54M$2.94M
2026-03-31-$519.00K*-$29.00K*-$51.00K*$161.00K*
2025-12-31-$764.00K*-$47.00K*-$56.00K*$266.00K*
2025-09-30-$635.00K*-$10.00K*-$83.00K*$0.00*
2025-06-30-$2.02M-$106.00K-$81.00K$0.00-$1.77M
2025-03-31-$95.00K*-$47.00K*-$81.00K*$0.00*
2024-12-31$565.00K*-$2.00K*-$82.00K*$790.00K*
2024-09-30$354.00K*-$26.00K*-$122.00K*$1.54M*
2024-06-30-$912.00K-$5.00K-$119.00K$748.00K-$539.00K
2024-03-31$152.00K*$18.00K*-$94.00K*$343.00K*
2023-12-31-$1.10M*-$1.00K*-$128.00K*$1.45M*
2023-09-30-$1.23M*-$2.00K*-$129.00K*$0.00*
2023-06-30-$215.00K-$17.00K-$130.00K-$5.00K-$276.00K
2023-03-31-$2.44M*-$82.00K*-$100.00K*-$100.00K*$2.87M*$704.00K*
2022-12-31-$348.00K*$34.00K*-$214.00K*$0.00*
2022-09-30-$1.83M*-$187.00K*
2022-06-30-$1.53M-$23.00K-$1.81M
2022-03-31-$1.40M*-$61.00K*$566.00K*$0.00*
2021-12-31-$326.00K*$0.00*-$199.00K*$662.00K
2021-09-30-$1.30M*$11.00K*-$198.00K*$6.90M
2021-06-30-$1.22M-$49.00K-$199.00K$0.00-$1.41M
2021-03-31-$1.48M*-$4.00K*$0.00*$0.00*
2020-12-31$746.00K*-$83.00K*-$49.00K*$0.00*$0.00*$1.22M*
2020-09-30-$357.00K*-$79.00K*-$216.00K*$0.00*-$1.49M*-$231.00K*
2020-06-30-$2.29M$554.00K-$216.00K$1.31M$1.49M$860.00K
2020-03-31-$3.59M*$3.68M*$0.00*$0.00*
2019-12-31-$840.00K*$33.00K*-$106.00K*$0.00*$1.38M*$495.00K*
2019-09-30-$898.00K*-$57.00K*-$105.00K*$0.00*$0.00*-$1.05M*
2019-06-30$738.00K-$12.00K-$123.00K$0.00$0.00$595.00K
2019-03-31-$2.75M*-$8.00K*$134.00K*$0.00*-$2.81M*
2018-12-31-$2.36M*-$28.00K*-$78.00K*$0.00*$4.97M*$2.45M*
2018-09-30-$3.55M*-$80.00K*-$123.00K*$41.00K*-$3.64M*
2018-06-30-$3.06M-$15.00K-$87.00K$916.00K-$2.38M
2018-03-31$1.44M*
2017-12-31-$2.16M*-$17.00K*-$41.00K*$968.00K*-$1.36M*
2017-09-30-$2.60M*-$5.00K*-$40.00K*$0.00*-$2.65M*
2017-06-30-$4.63M-$171.00K-$40.00K$0.00-$4.82M
2017-03-31-$2.69M*$992.00K*-$11.00K*$0.00*-$1.52M*
2016-12-31-$1.47M*$17.29M*-$19.00K*$0.00*$15.73M*
2016-09-30-$1.62M*-$48.00K*-$52.00K*$0.00*-$1.72M*
2016-06-30-$2.38M-$11.00K-$48.00K$0.00-$2.50M
2016-03-31-$1.72M*$11.00K*-$32.00K*$3.19M*$1.36M*
2015-12-31-$2.69M*-$120.00K*$0.00*$948.00K-$1.86M*
2015-09-30-$1.75M*-$78.00K*-$35.00K*$1.12M-$778.00K*
2015-06-30-$2.58M$4.38M-$52.00K$879.00K$2.62M
2015-03-31-$2.63M*$915.00K*-$35.00K*$5.69M*$3.90M*
2014-12-31-$1.05M*-$63.00K*-$2.00K*-$1.31M*
2014-09-30-$1.66M*$31.00K*-$56.00K*$261.00K*-$1.44M*
2014-06-30-$1.35M-$8.00K-$83.00K$952.00K-$493.00K
2014-03-31-$1.49M*-$17.00K*-$91.00K*$1.19M*$2.46M*$2.04M*
2013-12-31-$947.00K*-$116.00K*-$386.00K*$2.00M*$247.00K*
2013-09-30-$1.40M*-$142.00K*-$390.00K*$0.00*-$2.19M*
2013-06-30-$1.06M-$170.00K-$748.00K$0.00-$509.00K*-$2.52M
2013-03-31-$1.04M*-$116.00K*-$575.00K*$3.05M*$1.30M*
2012-12-31-$1.10M*-$49.00K*-$534.00K*-$35.00K*-$1.71M*
2012-09-30$4.56M*-$172.00K*-$507.00K*$0.00*$3.91M*
2012-06-30-$1.26M-$33.00K-$467.00K*$1.93M$1.05M
2012-03-31-$1.31M*-$135.00K*-$299.00K*$0.00*$0.00*-$1.61M*
2011-12-31-$1.25M*-$51.00K*-$290.00K*$1.00M*$1.89M*$1.34M*
2011-09-30-$939.00K*-$96.00K*-$318.00K*$0.00*-$16.00K*-$1.40M*
2011-06-30-$529.00K-$78.00K-$257.00K$1.50M$16.00K$654.00K
2011-03-31-$74.00K*-$101.00K*-$208.00K*$0.00*$65.00K*-$302.00K*
2010-12-31-$1.63M*-$10.00K*-$54.00K*$1.00M*-$694.00K*
2010-09-30-$1.23M*-$25.00K*-$77.00K*$0.00*-$1.30M*
2010-06-30-$1.49M-$28.00K-$71.00K$2.00M$409.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26